G W Pogson1, L H Kindred, B G Carper. Show Affiliations » 1. Mid-America Heart Institute of St. Luke's Hospital, Kansas City, Missouri, USA.
Abstract
Entities: Chemical Disease
Mesh: See more » AgedDrug InteractionsDrug Therapy, CombinationFemaleGemfibrozil/administration & dosageGemfibrozil/adverse effectsHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosageHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsHypolipidemic Agents/administration & dosageHypolipidemic Agents/adverse effectsPyridines/administration & dosagePyridines/adverse effectsRenal Insufficiency/chemically inducedRhabdomyolysis/chemically induced
Substances: See more » Hydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsPyridinescerivastatinGemfibrozil
Year: 1999 PMID: 10190540 DOI: 10.1016/s0002-9149(99)00034-x
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778